| Content is current as of date of release, subject to change without notice. |
 |
March 2, 2010
New Microza™ submerged membrane module for high-turbidity feed water |
|
January 21, 2010
Change in Representative Directors |
|
December 24, 2009
Integration of Bioprocess Businesses in North America |
|
December 24, 2009
Result of arbitration with CoTherix, Inc. of the US |
|
December 4, 2009
Issuance of unsecured straight bonds |
|
October 28, 2009
Start-up of medical device sales subsidiary in Korea |
|
September 30, 2009
Launch of Reveal® DX Insertable Cardiac Monitor |
|
September 28, 2009
Acquisition of shares in Med-Tech Inc. |
|
September 17, 2009
Construction of new plant for therapeutic apheresis devices |
|
September 7, 2009
US Clinical Study Approval for the Evaheart™ LVAS |
|
September 1, 2009
Start of operation at new integrated research complex |
|
August 5, 2009
Joint venture agreement for consolidation of fertilizer operations |
|
August 5, 2009
Change of proportion of shareholding in PS Japan Corp. |
|
July 3, 2009
Dissolution of the joint venture Solotex Corporation |
|
June 30, 2009
Conclusion of memorandum for acetonitrile production in Thailand |
|
June 23, 2009
Microza™ MF selected for large-scale waterworks facility in the Philippines |
|
June 15, 2009
Launch of Planova™ BioEX Virus Filters for Biopharmaceutical Processing |
|
June 4, 2009
Strategic review of Growth Action – 2010 mid-term initiative |
|
June 2, 2009
Study for unification of naphtha cracker operations in Mizushima |
|
May 19, 2009
Conclusion of multi-faceted business alliance |
|
May 12, 2009
Closure of Shiraoi Plant of Asahi Kasei Construction Materials and withdrawal of fine chemicals business of Asahi Kasei Pharma |
|
April 15, 2009
License agreement for development and sale of Flivas™ in Korea |
|
April 7, 2009
Basic agreement for overseas business development for Evaheart™ ventricular assist system |
|
